Download PDF
Dtsch Med Wochenschr 2021; 146(05): 309-316
DOI: 10.1055/a-1235-0422
Dossier

Versorgung von Herzinsuffizienzpatienten – eine interdisziplinäre Herausforderung

Care of patients with chronic heart failure: an interdisciplinary challenge
Stefan Störk
,
Christiane Angermann
,
Johann Bauersachs
,
Stefan Frantz
› Further Information
Also available at
    Permissions and Reprints

Die mannigfachen Erscheinungsbilder der Herzinsuffizienz führten zu komplexen Behandlungsleitlinien und Versorgungsszenarien und erfordern deshalb immer einen integrierten, multidisziplinären Versorgungsansatz. Die stetige Entwicklung der diagnostischen Möglichkeiten und Therapieoptionen muss konsequent in die Versorgung implementiert werden und erfordert eine gute Zusammenarbeit zwischen den ärztlichen und pflegenden Fachgruppen.

Abstract

The diverse manifestations of heart failure led to complex treatment guidelines and care scenarios and therefore always require an integrated, multidisciplinary care approach. Patients with chronic heart failure suffer from a large number of cardiac and noncardiac comorbidities. For example, iron deficiency leads to decreased performance and exertional dyspnea and should be diagnosed. Psychological screening questionnaires should be used for the early detection of psychological comorbidities.

ARNI and SGLT-inhibitors expand the pharmacotherapeutic possibilities and gain in importance. The constant development of diagnostic possibilities and therapeutic options must be implemented consistently into the care continuum in order to have a lasting effect. The challenge of interdisciplinary coordination can be significantly reduced through jointly agreed process logs (e. g. within the framework of integrated supply contracts or a Heart Failure Unit Network).

Schlüsselwörter

chronische Herzinsuffizienz - Komorbidität - Eisenmangel - Psyche - ARNI - SGLT2-Inhibitor - interdisziplinär

Key words

chronic heart failure - comorbidity - iron deficiency - psyche - ARNI - SGLT2 inhibitor - interdisciplinary


Publication History

Article published online:
01 March 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Letter to this article:

Zum Beitrag: „Versorgung von Herzinsuffizienzpatienten – eine interdisziplinäre Herausforderung“Dtsch Med Wochenschr 2021; 146(17): 1166-1167
DOI: 10.1055/a-1430-4504

 

  • Literatur

  • 1 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz – Langfassung, 3. Aufl. Version 2. 2019 – Update 2020 [cited 2021 Jan 7].
    Google Scholar
  • 2 Ponikowski P, Voors AA, Anker SD. et al 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891-975 . doi:10.1002/ejhf.592
    CrossrefPubMedGoogle Scholar
  • 3 Berliner D, Schneider N, Welte T. et al The Differential Diagnosis of Dyspnea. Dtsch Arztebl Int 2016; 113: 834-845 . doi:10.3238/arztebl.2016.0834
    CrossrefPubMedGoogle Scholar
  • 4 Haddad S, Wang Y, Galy B. et al Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J 2017; 38: 362-372 . doi:10.1093/eurheartj/ehw333
    PubMedGoogle Scholar
  • 5 Hirsch VG, Tongers J, Bode J. et al Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction. Eur J Heart Fail 2020; 22: 2038-2046 . doi:10.1002/ejhf.1781
    CrossrefPubMedGoogle Scholar
  • 6 Anker SD, Kirwan BA, van Veldhuisen DJ. et al Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail 2018; 20: 125-133 . doi:10.1002/ejhf.823
    CrossrefPubMedGoogle Scholar
  • 7 Anker SD, Comin Colet J, Filippatos G. et al Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-2448 . doi:10.1056/NEJMoa0908355
    CrossrefPubMedGoogle Scholar
  • 8 Ponikowski P, Kirwan BA, Anker SD. et al Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 2020; 396: 1895-1904 . doi:10.1016/S0140-6736(20)32339-4
    CrossrefPubMedGoogle Scholar
  • 9 Lewis GD, Malhotra R, Hernandez AF. et al Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA 2017; 317: 1958-1966 . doi:10.1001/jama.2017.5427
    CrossrefPubMedGoogle Scholar
  • 10 Olsson KM, Fuge J, Brod T. et al Oral iron supplementation with ferric maltol in patients with pulmonary hypertension. Eur Respir J 2020; 56 DOI: 10.1183/13993003.00616-2020.
    CrossrefPubMedGoogle Scholar
  • 11 Jha MK, Qamar A, Vaduganathan M. et al Screening and management of depression in patients with cardiovascular disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2019; 73: 1827-1845 . doi:10.1016/j.jacc.2019.01.041
    CrossrefPubMedGoogle Scholar
  • 12 Schowalter M, Gelbrich G, Störk S. et al Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression. Clin Res Cardiol 2013; 102: 269-278 . doi:10.1007/s00392-012-0531-4
    CrossrefPubMedGoogle Scholar
  • 13 Celano CM, Villegas AC, Albanese AM. et al Depression and anxiety in heart failure: a review. Harv Rev Psychiatry 2018; 26: 175-184 . doi:10.1097/HRP.0000000000000162
    CrossrefPubMedGoogle Scholar
  • 14 Kahl KG, Stapel B, Frieling H. Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism. Prog Neuropsychopharmacol Biol Psychiatry 2019; 89: 146-157 . doi:10.1016/j.pnpbp.2018.09.004
    CrossrefPubMedGoogle Scholar
  • 15 Angermann CE, Kaspar M, Marx A. et al A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study. Eur J Heart Fail 2017; 19: 314-323 . doi:10.1002/ejhf.706
    CrossrefPubMedGoogle Scholar
  • 16 Angermann CE, Ertl G. Depression, Anxiety, and Cognitive Impairment: Comorbid Mental Health Disorders in Heart Failure. Curr Heart Fail Rep 2018; 15: 398-410 . doi:10.1007/s11897-018-0414-8
    CrossrefPubMedGoogle Scholar
  • 17 Pina IL, Di Palo KE, Ventura HO. Psychopharmacology and Cardiovascular Disease. J Am Coll Cardiol 2018; 71: 2346-2359 . doi:10.1016/j.jacc.2018.03.458
    CrossrefPubMedGoogle Scholar
  • 18 Angermann CE, Gelbrich G, Störk S. et al Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. JAMA 2016; 315: 2683-2693 . doi:10.1001/jama.2016.7635
    CrossrefPubMedGoogle Scholar
  • 19 He W, Zhou Y, Ma J. et al Effect of antidepressants on death in patients with heart failure: a systematic review and meta-analysis. Heart Fail Rev 2020; 25: 919-926 . doi:10.1007/s10741-019-09850-w
    CrossrefPubMedGoogle Scholar
  • 20 Angermann CE, Assmus B, Anker SD. et al Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). Eur J Heart Fail 2020; 22: 1891-1901 . doi:10.1002/ejhf.1943
    CrossrefPubMedGoogle Scholar
  • 21 Angermann CE, Störk S, Gelbrich G. et al Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 2012; 5: 25-35 . doi:10.1161/CIRCHEARTFAILURE.111.962969
    CrossrefPubMedGoogle Scholar
  • 22 Frey A, Sell R, Homola GA. et al Cognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure. JACC Heart Fail 2018; 6: 583-592 . doi:10.1016/j.jchf.2018.03.010
    CrossrefPubMedGoogle Scholar
  • 23 Frey A, Homola GA, Henneges C. et al Temporal changes in total and hippocampal brain volume and cognitive function in patients with chronic heart failure – The COGNITION.MATTERS-HF cohort study. Eur Heart J 2021 DOI: 10.1093/eurheartj/ehab003
    Google Scholar
  • 24 Berliner D, Hanselmann A, Bauersachs J. The Treatment of Heart Failure with Reduced Ejection Fraction. Dtsch Arztebl Int 2020; 117: 376-386 . doi:10.3238/arztebl.2020.0376
    CrossrefPubMedGoogle Scholar
  • 25 Seferovic PM, Ponikowski P, Anker SD. et al Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019; 21: 1169-1186 . doi:10.1002/ejhf.1531
    CrossrefPubMedGoogle Scholar
  • 26 Störk S, Handrock R, Jacob J. et al Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 2017; 106: 923-932 . doi:10.1007/s00392-017-1138-6
    CrossrefPubMedGoogle Scholar
  • 27 Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J 2021; DOI: 10.1093/eurheartj/ehaa1012.
    CrossrefPubMedGoogle Scholar
  • 28 McMurray JJV, Packer M. How should we sequence the treatments for heart failure and a reduced ejection fraction? A redefinition of evidence-based medicine. Circulation 2020; DOI: 10.1161/CIRCULATIONAHA.120.052926.
    CrossrefPubMedGoogle Scholar
  • 29 Adamson PB, Abraham WT, Bourge RC. et al Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail 2014; 7: 935-944 . doi:10.1161/CIRCHEARTFAILURE.113.001229
    CrossrefPubMedGoogle Scholar
  • 30 Beschluss des Gemeinsamen Bundesausschusses über die 11. Änderung der DMP-Anforderungen Richtlinie: Änderung der Anlagen 2 und 5, Ergänzung der Anlage 13 (DMP Herzinsuffizienz) und Anlage 14 (Herzinsuffizienz Dokumentation). Im Internet (Stand: 16.01.2021): https://www.g-ba.de/beschluesse/3299/
    Google Scholar
  • 31 Ertl G, Angermann CE, Bekeredjian R. et al Aufbau und Organisation von Herzinsuffizienz-Netzwerken (HF-NETs) und Herzinsuffizienz-Einheiten („Heart Failure Units“, HFUs) zur Optimierung der Behandlung der akuten und chronischen Herzinsuffizienz. Kardiologe 2016; 10: 222-235 . doi:10.1007/s12181-016-0072-6
    CrossrefPubMedGoogle Scholar
  • 32 Gorodeski EZ, Goyal P, Cox ZL. et al Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America. J Card Fail 2020; 26: 448-456 . doi:10.1016/j.cardfail.2020.04.008
    CrossrefPubMedGoogle Scholar